Cargando…

Biopatent Law: Patent Strategies and Patent Management

Patents protecting biotechnological invention become ever more important. Because biotechnology has many differences with respect to other technologies, lessons learned in other fields of technology cannot simply be transferred to adopt a suitable strategy for dealing with biotechnology inventions....

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores principales: Hübel, Andreas (Autor), Schmelcher, Thilo (Autor), Storz, Ulrich (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2012.
Edición:1st ed. 2012.
Colección:SpringerBriefs in Biotech Patents,
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-642-24846-7
003 DE-He213
005 20220113002628.0
007 cr nn 008mamaa
008 120103s2012 gw | s |||| 0|eng d
020 |a 9783642248467  |9 978-3-642-24846-7 
024 7 |a 10.1007/978-3-642-24846-7  |2 doi 
050 4 |a QH573-671 
072 7 |a PSF  |2 bicssc 
072 7 |a SCI049000  |2 bisacsh 
072 7 |a PSF  |2 thema 
082 0 4 |a 571.6  |2 23 
100 1 |a Hübel, Andreas.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Biopatent Law: Patent Strategies and Patent Management  |h [electronic resource] /  |c by Andreas Hübel, Thilo Schmelcher, Ulrich Storz. 
250 |a 1st ed. 2012. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2012. 
300 |a XII, 44 p. 1 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a SpringerBriefs in Biotech Patents,  |x 2192-9912 
505 0 |a Andreas Huebel: General Issues of Biotech Patents -- Thilo Schmelcher: Active and Passive Patent Strategies -- Ulrich Storz: Patent Lifetime Management, SPCs and Data Exclusivity. 
520 |a Patents protecting biotechnological invention become ever more important. Because biotechnology has many differences with respect to other technologies, lessons learned in other fields of technology cannot simply be transferred to adopt a suitable strategy for dealing with biotechnology inventions. In this volume, general aspects of biopatent law will be discussed. This involves questions of patentability, including ethical issues and issues of technicality, as well as questions of patent exhaustion in cases were reproducible subject matter, like cells or seeds, is protected. Moreover, active and passive patent strategies are addressed. Further, insight will be given into patent lifetime management and additional protective measures, like supplementary protection certificates and data exclusivity. Here, strategies are discussed how market exclusivity can be extended as long as possible, which is particularly important for biopharmaceutical drugs, which create high R&D costs. 
650 0 |a Cytology. 
650 0 |a Pharmaceutical chemistry. 
650 0 |a Microbiology. 
650 0 |a Biochemistry. 
650 0 |a Biotechnology. 
650 0 |a Commercial law. 
650 1 4 |a Cell Biology. 
650 2 4 |a Pharmaceutics. 
650 2 4 |a Microbiology. 
650 2 4 |a Biochemistry. 
650 2 4 |a Biotechnology. 
650 2 4 |a Commercial Law. 
700 1 |a Schmelcher, Thilo.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
700 1 |a Storz, Ulrich.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783642248450 
776 0 8 |i Printed edition:  |z 9783642248474 
830 0 |a SpringerBriefs in Biotech Patents,  |x 2192-9912 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-642-24846-7  |z Texto Completo 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)